Mike Kelliher

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2023

3 years of board service in total across 1 board, counting each seat separately. Longest: Capricor Therapeutics Inc., 3 years.

3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Aug 21, 2026 Ardelyx Inc. Open-market sale −3,104 $3.86 $11,981
Aug 21, 2026 Ardelyx Inc. Open-market sale −2,652 $3.86 $10,237
Aug 21, 2026 Ardelyx Inc. Open-market sale −2,002 $3.86 $7,728
May 21, 2026 Ardelyx Inc. Open-market sale −2,900 $6.27 $18,183
May 21, 2026 Ardelyx Inc. Open-market sale −1,870 $6.27 $11,725
May 21, 2026 Ardelyx Inc. Open-market sale −2,478 $6.27 $15,537
Feb 20, 2026 Ardelyx Inc. Open-market sale −8,434 $5.87 $49,508
Feb 20, 2026 Ardelyx Inc. Open-market sale −1,159 $5.71 $6,618
Feb 20, 2026 Ardelyx Inc. Open-market sale −2 $5.71 $11
Jan 23, 2026 Ardelyx Inc. Grant or award +103,080 — —
Nov 21, 2025 Ardelyx Inc. Open-market sale −5,560 $5.54 $30,802
Aug 21, 2025 Ardelyx Inc. Open-market sale −5,417 $5.93 $32,123
May 20, 2025 Ardelyx Inc. Open-market sale −14,522 $4.08 $59,250
Feb 25, 2025 Ardelyx Inc. Grant or award +136,680 — —
Mar 25, 2024 Ardelyx Inc. Grant or award +160,000 — —

Questions about Mike Kelliher

What boards is Mike Kelliher on?

Mike Kelliher sits on the board of Capricor Therapeutics Inc.

How long has Mike Kelliher served on boards?

Our records show at least 3 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.